Safety of Glycoprotein IIb-IIIa Inhibitors Used in Stroke-Related Treatment: A Systematic Review and Meta-Analysis

BACKGROUND: Endovascular therapy and intravenous thrombolysis with recombinant tissue plasminogen activator are the 2 most recommended treatments for acute ischemic stroke (AIS). Glycoprotein (GP) IIb-IIIa inhibitors are short-acting selective reversible antiplatelet agents that emerged as promising...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Xiaolin, Cao, Genmao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7394033/
https://www.ncbi.nlm.nih.gov/pubmed/32727211
http://dx.doi.org/10.1177/1076029620942594

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7394033/
https://www.ncbi.nlm.nih.gov/pubmed/32727211
http://dx.doi.org/10.1177/1076029620942594

Ejemplares similares